• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水蛭素对用十种不同试剂测定的活化部分凝血活酶时间的影响。

Effects of hirudin on activated partial thromboplastin time determined with ten different reagents.

作者信息

Tripodi A, Chantarangkul V, Arbini A A, Moia M, Mannucci P M

机构信息

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital, Milano, Italy.

出版信息

Thromb Haemost. 1993 Aug 2;70(2):286-8.

PMID:8236136
Abstract

Hirudin prolongs the APTT when added to normal plasma and the extent of prolongation depends on the type of reagent used. The aim of this study was to compare the dose-response curves of 10 widely used APTT reagents for linearity and parallelism. On each of 10 working days a normal pooled plasma was mixed with increasing amounts of recombinant hirudin (HBW023) ranging from 0 to 5 micrograms/ml and tested for APTT by photo optical coagulometer. Within each working day, clotting times were measured in duplicate and the order of testing with each reagent was changed every day. Results were expressed as ratios of clotting times with hirudin to clotting times without hirudin, and the values plotted against the hirudin concentration on a log-log scale. The dose-response curves for all reagents were linear over 0.3-1.2 micrograms/ml. The reagent-related slopes ranged from 0.225 +/- 0.003 to 0.303 +/- 0.003 (mean +/- SE) and were significantly different. Precision studies indicated that the least sensitive reagent was also the least precise. These findings indicate that the clotting time values obtained for patients treated with hirudin will vary depending on the APTT reagent used.

摘要

水蛭素添加到正常血浆中时会延长活化部分凝血活酶时间(APTT),延长程度取决于所用试剂的类型。本研究的目的是比较10种广泛使用的APTT试剂的剂量反应曲线的线性和平行性。在10个工作日中的每一天,将正常混合血浆与重组水蛭素(HBW023)按0至5微克/毫升的量递增混合,并用光学凝血仪检测APTT。在每个工作日内,凝血时间进行双份测量,且每天改变每种试剂的检测顺序。结果表示为有水蛭素时的凝血时间与无水蛭素时的凝血时间之比,并将这些值在对数-对数尺度上相对于水蛭素浓度作图。所有试剂的剂量反应曲线在0.3至1.2微克/毫升范围内呈线性。试剂相关的斜率范围为0.225±0.003至0.303±0.003(平均值±标准误),且有显著差异。精密度研究表明,最不敏感的试剂也是最不精确的。这些发现表明,接受水蛭素治疗的患者所获得的凝血时间值将因所用的APTT试剂而异。

相似文献

1
Effects of hirudin on activated partial thromboplastin time determined with ten different reagents.水蛭素对用十种不同试剂测定的活化部分凝血活酶时间的影响。
Thromb Haemost. 1993 Aug 2;70(2):286-8.
2
Effects of two different doses of hirudin on APTT, determined with eight different reagents.
Thromb Haemost. 1995 Feb;73(2):219-22.
3
Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers.聚乙二醇化水蛭素在健康志愿者中的药效学和安全性结果。
Thromb Haemost. 1997 May;77(5):911-9.
4
Experimental studies on a recombinant hirudin, CGP 39393.重组水蛭素CGP 39393的实验研究
Thromb Haemost. 1991 Apr 8;65(4):355-9.
5
Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.使用活化部分凝血活酶时间监测肝素治疗——一项多中心试验的结果,该试验确定了对肝素高度敏感的试剂SILIMAT的治疗范围。
Thromb Haemost. 1998 Jul;80(1):104-8.
6
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents.硫酸皮肤素对用不同试剂测定的活化部分凝血活酶时间的影响。
Haemostasis. 1997 Mar-Apr;27(2):85-90. doi: 10.1159/000217438.
7
Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.使用活化部分凝血活酶时间、蛇静脉酶凝血时间和凝血酶抑制剂管理测试比较直接凝血酶抑制剂。
Ann Pharmacother. 2004 Sep;38(9):1383-8. doi: 10.1345/aph.1D565. Epub 2004 Jul 6.
8
Laboratory assays for the evaluation of recombinant hirudin.用于评估重组水蛭素的实验室检测方法。
Haemostasis. 1991;21 Suppl 1:49-63. doi: 10.1159/000216263.
9
Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assays.
Thromb Haemost. 1994 Nov;72(5):685-92.
10
The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.抑肽酶对活化部分凝血活酶时间(APTT)对肝素反应的影响。
Blood Coagul Fibrinolysis. 1993 Feb;4(1):35-40.

引用本文的文献

1
Reversible crystallization of argatroban after subcutaneous application in pigs.猪皮下给药后阿加曲班的可逆结晶
Thrombosis. 2012;2012:560513. doi: 10.1155/2012/560513. Epub 2012 Sep 3.
2
Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?急性冠状动脉综合征患者的管理:直接凝血酶抑制剂的临床作用是什么?
Drugs. 2002;62(13):1839-52. doi: 10.2165/00003495-200262130-00001.
3
Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease.
凝血酶抑制剂伊诺加群对健康受试者和冠状动脉疾病患者体外凝血时间(活化部分凝血活酶时间)影响的群体建模。
Br J Clin Pharmacol. 2001 Jan;51(1):71-9. doi: 10.1046/j.1365-2125.2001.01326.x.
4
Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin.水蛭素及其衍生物的药理特性。相对于肝素的潜在临床优势。
Drugs Aging. 1996 Mar;8(3):171-82. doi: 10.2165/00002512-199608030-00003.
5
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393).
Eur J Clin Pharmacol. 1995;48(3-4):241-6. doi: 10.1007/BF00198305.